that lacked a somatic phenotype in our assay (Figure 2 ). 
Introduction
HMGCoAR notypes along with the EC 50 s of these phenotypes were (PGCs) fail to reach their correct target in the mesoderm identical for both drugs. After mevinolin or simvastatin (Van Doren et al., 1998). Importantly, cholesterol or its treatment, PGCs were widely dispersed, whereas underivatives do not participate in producing the signal treated animals had a compact cluster of PGCs in the required for germ cell migration, because Drosophila anterior yolk extension (data not shown). To demonlacks a number of enzymes necessary for de novo chostrate that the PGC migration phenotype represented a lesterol synthesis (Santos and Lehmann, 2004) . primary defect in this process and was not due to defects in somatic patterning (Supplemental Figure S2 ), embryos were treated with atorvastatin, the only statin that lacked a somatic phenotype in our assay (Figure 2 ). (Figures 2A-2C ) without the severe morphological defects observed with the other statins ( Figure 2D) . cue of the PGC migration phenotype caused by all three statins ( Figure 3C ). As a control, embryos were injected Embryos treated with atorvastatin showed a PGC migration phenotype at the end of gastrulation, resulting in with sodium citrate, a salt with a similar molecular weight as mevalonate, prior to statin treatment, and this failed PGCs that failed to align along the anterior and lateral borders of the trunk mesoderm. By the 3-somite stage, to reverse the PGC phenotype (data not shown). Mevalonate not only reversed the PGC migration defects caused over 90% of the embryos had ectopic germ cells compared to less than 20% in the wild-type ( Figure 2E) . by statin treatment, but also fully rescued the somatic phenotype caused by mevinolin and simvastatin ( Figure  Furthermore , the effect of atorvastatin on PGC migration was dose dependent (EC 50 4 M) ( Figure 2F normal PGC migration and were as equally protected as embryos injected with mevalonate ( Figure 3E ). FarneTo test whether the isoprenoid synthesis branch of the pathway (via geranylgeranyl transferases and farnesyl sol is an alcohol that can elevate cellular farnesyl diphosphate, a precursor required both by geranylgeranyl transferases) mediates the effect of statins on PGC migration, we injected embryos with compounds that transferase and farnesyl transferase (Figure 1) . Injection of farnesol also rescued the PGC migration defect of would increase the cellular levels of the substrates of these enzymes before immersion in atovastatin (10 M).
embryos from statin treatment ( Figure 3E ). Our results support the idea that the PGC migration defect induced Embryos injected with geranylgeraniol, an alcohol that 
by statins is the result of impaired geranylgeranylation
Geranylgeranyl Transferase Activity Is Required for Correct PGC Migration of target proteins caused by reduction in cellular geranylgeranyl diphosphate (Figure 1) (Figlong- The present study utilizes highly specific enzyme inmental Figure S3 ). Similar to hmgcr2 expression, materhibitors to identify likely regulators of PGC migration. nal ggt1 transcripts were evident in 4-cell stage embryos This approach has a number of advantages in that multiand uniform expression was observed during gastrulaple isoforms and not individual proteins can be targeted. tion (Supplemental Figures S1 and S3) . These data sugAdditionally, when genetic studies impair zygotic gene gest that GGT1 is present in positions where the PGCs expression, residual maternally derived protein, which migrate. may be experimentally difficult if not impossible to eliminate, can mask the corresponding phenotype. ConDo SDF-1 and HMGCoAR Act in the Same Pathway versely, it can be difficult to establish that the phenotype to Regulate PGC Migration?
resulting from soaking whole embryos in a pharmacoPreviously, it was shown that the G protein-coupled logic reagent results from the specific inhibition of a receptor CXCR4b and its ligand SDF-1a provide direcprotein or protein family. We addressed this issue by tional guidance cues to migrating PGCs. One possibility injecting embryos with mevalonate prior to their expoto explain the effect of statin treatment on PGC migration sure to statins. This procedure rescued all phenotypes could be that HMGCoAR activity is required for the exassociated with statin treatment, supporting the notion pression or activity of the SDF-1 ligand. We therefore that the observed effect is specific to the mevalonate analyzed the expression of sdf-1a in statin-treated empathway (Figure 3 ). bryos and found that atorvastatin treatment did not alter Although mevalonate rescued the effect of all the statsdf-1a expression (Figures 4F and 4G) . To further test ins utilized in this study, the phenotypes induced by if statins and the SDF-1a receptor CXCR4b function the different statins were not identical. Simvastatin and together or independently, we impaired both pathways mevinolin produced more severe somatic phenotypes by injecting atorvastatin and morpholino antisense olithan atorvastatin, one of the most hydrophobic statins. gonucleotides directed against cxcr4b (Heasman et al.,
One possibility is that atorvastatin partitions into the 2000; Nasevicius and Ekker, 2000). Doses were selected yolk, which may limit both the availability and concentrato induce mild migration defects. The combined effect tion of the drug within the embryo. of atorvastatin and cxcr4b morpholino was not greater Our observation that atorvastatin-induced PGC mithan the sum of each independent treatment (Figure gration defects were rescued by both geranylgeraniol 4H), indicating that HMGCoAR and SDF-1a function in and farnesol points to a potential role for geranylgeranyl distinct pathways. transferase or farnesyl transferase activities in this process. However, two farnesyl transferase inhibitors failed Discussion to show any effect on PGC migration, while a GGT1-specific inhibitor (Sun et al., 1999 ) demonstrated a role The results of this study indicate that pharmacologic for geranylgeranylated rather than farnesylated proteins inhibition of protein prenylation, either through the inhiin the process. The fact that farnesol also rescued atorbition of GGT1 directly or by limiting the supply of prevastatin-induced migration defects could be due to the cursors for the reaction it catalyzes, impairs the migration of PGCs. The observation that correct PGC presence of enough cellular isopentenyl diphosphate 
